KL-6
Back to Test Catalogue
Krebs von den Lungen-6, Serum
Test ID: KVDL6 S
Test
Aliases/Synonyms
Method
Quantitative Immunoturbidimetric
Report Includes
Krebs von den Lungen-6
Specimens
Serum
Clinical Utility
May aid in the evaluation of lung inflammation or injury in various types of ILD.
Krebs von den Lungen-6 (KL-6) may be an indicator of lung inflammation or damage. Elevated levels are associated with various types of interstitial lung diseases (ILD).
Abnormal KL-6 results should be interpreted in the appropriate clinical context. A negative result does not rule out ILD.
Test Location
ARUP Laboratories, 500 Chipeta Way, Salt Lake City, Utah 84108, USA
Test Version
7-Feb-2020
Specimen
Specimens
Serum
Collection Containers
Red top (no additive)
Sample Volume
1.5 mL
Minimum Volume
0.5 mL
Collection & Handling
Handling Information
Spin and separate within 2 hours. Store and send frozen.
Stability
| Ambient | 48 hours |
|---|---|
| Refrigerated | 2 weeks |
| Frozen | 1 month |
Rejection Criteria
| Hemolysis | Present |
|---|---|
| Lipemia | Hyperlipemic |
| Other | Icteric |
| Specimen | Heat-treated or contaminated |
Test Version
7-Feb-2020
Performance / Interpretation
Method
Quantitative Immunoturbidimetric
Turnaround Time
13 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Krebs von den Lungen-6 | U/mL |
|
||
|
Samples with results greater than 10,000 U/mL will be diluted to the maximum reportable range (>40,000 U/mL).
Krebs von den Lungen-6 (KL-6) may be an indicator of lung inflammation or damage. Elevated levels are associated with various types of interstitial lung diseases (ILD). Abnormal KL-6 results should be interpreted in the appropriate clinical context. A negative result does not rule out ILD. ARUP Compliance Statement D: For laboratory tests using a manufactured RUO kit. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. |
||||
Test Location
ARUP Laboratories, 500 Chipeta Way, Salt Lake City, Utah 84108, USA
Test Version
7-Feb-2020
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| KVDL6 S | 63258Krebs von den Lungen-6 | U/mL |
Test Version
7-Feb-2020